Evidence map›Paper›PMID 33911065›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2021

miR-1283 Contributes to Endoplasmic Reticulum Stress in the Development of Hypertension Through the Activating Transcription Factor-4 (ATF4)/C/EBP-Homologous Protein (CHOP) Signaling Pathway.

Weihao Chen, Tianhao Liu, Qiuer Liang, Xudong Chen, Wencong Tao, Meixia Fang, Ya Xiao, Liguo Chen

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Heliyon · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Weihao ChenCollege of Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).
Tianhao LiuCollege of Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).
Qiuer LiangCollege of Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).
Xudong ChenCollege of Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).
Wencong TaoCollege of Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).
Meixia FangCollege of Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).
Ya XiaoCollege of Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).
Liguo ChenCollege of Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).
Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Hypertension-related microRNA(miR)-1283 and its target gene, activating transcription factor-4 (ATF4), can regulate vascular endothelial dysfunction. This study aimed to explore whether miR-1283 prevents hypertension through targeting ATF4. MATERIAL AND METHODS Transcriptome sequencing was performed after overexpression or inhibition of miR-1283 in human amniotic epithelial cells (HAECs). After miR-1283 was overexpressed or inhibited in HAECs, ATF4+/- and wild-type mice were induced with a high-salt diet. We detected the expression of ATF4, C/EBP-homologous protein (CHOP), BH3-interacting domain death agonist (BID), Bcl-2, Bcl-2-like protein 11 (BIM), Bcl-2-like protein 1 (BCL-X), and caspase-3 by PCR and western blotting. We detected the changes of vasoactive substances including nitric oxide (NO), endothelin 1 (ET-1), endothelial protein C receptor (EPCR), thrombin (TM), and von Willebrand factor (vWF) by ELISA. RESULTS Compared with that of the miR-1283- inhibited group, NO was higher in the miR-1283 overexpression group, while the expression of ET-1, EPCR, TM, and vWF were lower. Similarly, compared with that of the miR-1283 inhibited group, the expression of ATF4, CHOP, BID, BIM, and caspase-3 in the miR-1283 overexpression group was downregulated, while the expression of BCL-2 and BCL-X was upregulated (P<0.05). In vivo experiments showed the lack of ATF4 gene could prevent hypertension in mice induced by high-salt diet and protect endothelial function. CONCLUSIONS The mechanism of regulating blood pressure and endothelial function of the miR-1283/ATF4 axis was related to inhibiting endoplasmic reticulum stress and cell apoptosis through the ATF4/CHOP signaling pathway. Therefore, the miR-1283/ATF4 axis may be a target for the prevention and treatment of hypertension.

Indexed as

Activating Transcription Factor 4AnimalsApoptosisBcl-2-Like Protein 11bcl-X ProteinBH3 Interacting Domain Death Agonist ProteinCells, CulturedDown-RegulationEndoplasmic Reticulum StressEpithelial CellsHumansHypertensionMaleMiceMice, Inbred C57BLMice, KnockoutActivating Transcription Factor 4ATF4 protein, humanBcl-2-Like Protein 11bcl-X ProteinBH3 Interacting Domain Death Agonist ProteinDDIT3 protein, humanMicroRNAsMIRN1283 microRNA, humanProto-Oncogene Proteins c-bcl-2Transcription Factor CHOP

Identifiers

PMID33911065
PMCPMC8095088
OpenAlexW3130815311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.